Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adera Labs
Germantown, Maryland, United States
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Developed a CLIA-approved diagnostic test to detect pancreatic cancer and inform chemotherapy regimens. The company’s blood-based assay analyzes tumor cell gene expression from patient blood samples to help predict which chemotherapeutic drugs may be most effective. Early results are promising but require larger clinical trials for broader adoption.
- Therapeutic areas
- Oncology
- Modalities
- Blood-based gene expression assayspharmacogenomic diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
Collaborations with academic medical centers such as Memorial Sloan Kettering Cancer Center on assay development and clinical studies
Beyond the preview
Go deeper on Adera Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adera Labs.